Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
2CUREX.ST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.22
N/A
-0.44
vs -0.12
Q2.22
N/A
-0.30
vs -0.35
Q3.22
N/A
-0.41
vs -0.31
Q4.22
N/A
-0.54
vs -0.38
Q1.23
N/A
-0.38
vs -0.44
Q2.23
N/A
-0.46
vs -0.30
Q3.23
N/A
-0.58
vs -0.41
Q4.23
N/A
-0.28
vs -0.54
Q1.24
N/A
-0.27
vs -0.38
Q2.24
N/A
-0.27
vs -0.46
Sales Growth
YoY
Current
Estimates
Q1.22
-89%
434K vs 3.9M
Q2.22
-98%
8K vs 469K
Q3.22
-98%
8K vs 530K
Q4.22
-97%
82K vs 2.5M
Q1.23
-97%
13K vs 434K
Q2.23
+738%
67K vs 8K
Q3.23
+988%
87K vs 8K
Q4.23
+622%
592K vs 82K
Q1.24
+1823%
250K vs 13K
Q2.24
+273%
250K vs 67K
Return on Equity
QoQ
Q4.22
-22%
-0.22
vs -0.14
Q1.23
-19%
-0.19
vs -0.22
Q2.23
-30%
-0.30
vs -0.19
Q3.23
-57%
-0.57
vs -0.30
Q4.23
-36%
-0.36
vs -0.57
Q1.24
-172%
-1.72
vs -0.36
Q2.24
-172%
-1.72
vs -1.72
Q4.24
NA
NA
vs -1.72
Institutionnal Ownership
Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
2CUREX.ST
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark.
STO
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.08Â ( -2.23%)
Relative Strenght
Volume Buzz
-99%
Earning Acce
No
Dist 52w H.
37%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 2CUREX.ST compares to sector?